Summary: The purpose of this study was to assess the accuracy of estimated blood loss (EBL) as a reliable predictor of actual blood loss during orthopedic procedures. Between 1999 and 2002, 198 
The estimated blood loss (EBL) is obtained for virtually every operation. Subsequent treatment of the patient is heavily influenced by this subjective datum. Before the acquisition of a postoperative hemoglobin (Hgb) level, the EBL is commonly used to determine whether or not a patient will receive blood products perioperatively. To our knowledge the EBL has not been previously appraised for its reliability or validity.
Studies have shown that gender, body weight and height are not good predictors of blood loss whereas a positive correlation exists between operative time, anesthetic technique, operative approach, exposure to nonsteroidal antiinflamma-Blood transfusion.
tory drugs, and the preoperative hemoglobin/hematocrit levels (1) (2) (3) (4) (5) (6) (7) (8) (9) . The primary concern raised in evaluating blood loss revolves around whether or not the surgical patient requires transfusion. Allogenic transfusions must provide optimal blood perfusion for recovery of the surgery but minimized to avoid fluid overload, respect ethical/religious concerns, and reduce exposure to bloodborne pathogens (10, 11) . Autologous blood transfusions have their own unique risks including iatrogenic anemia, and increased cost per unit of blood when compared to allogenic blood (12) (13) (14) . Interestingly, evidence is lacking that clearly shows improved outcome in transfused patients when compared to the Jehovah's Witnesses population in which the transfusion of blood products is denied (15) .
Guidelines for transfusion are controversial and not addressed by this study; however, by providing more information with regard to assessment and evaluation of the postoperative patient this study seeks to allow for a more informed decision with regard to the hemodynamic state of the patient.
The aims of this study were first, to identify the relationship between EBL and change in hemoglobin and second, to quantify the relationship in a manner that would be meaningful in managing hemostasis in the perioperative period.
METHODS
A structured PubMed search including the years 1965 to 2001 was conducted to identify English language articles examining the predictive value of estimated blood loss. Key words used in the search included blood loss, estimated blood loss, and perioperative blood loss.
Patients and Measurements
The study population included patients undergoing total knee and hip arthroplasty along with open reduction internal fixations (ORIF) from 1999 through 2002 at a community-based medical center. A retrospective chart analysis was performed collecting the demographics (age and sex) of the population along with pertinent laboratory data. The data included preoperative and postoperative values for hemoglobin, hematocrit, creatinine and blood urea nitrogen. The specific surgery, surgery time, amount of intravenous fluids given and estimated blood loss were obtained from operative procedure notes and the anesthesia operative notes. Patients who were given packed red blood cells prior to obtaining a postoperative complete blood cell count were excluded from the study.
Statistical Analysis
The clinical and demographic characteristics including amount of intravenous fluids received, preoperative and postoperative values for hemoglobin and hematocrit were described for the cohort overall. Univariate analyses estimated the associations between estimated blood loss and change in hemoglobin, hematocrit, surgical time and amount of intravenous fluids given, using the chi-square test for categorical parameters. In a similar manner, association between changes in hemoglobin and surgery time, IV fluids administered and hematocrit change was estimated using the chisquare test. A multiple linear regression was used to obtain a model to predict change in hemoglobin based on estimated blood loss and the amount of intravenous fluids received. All analysis were performed using SPSS V.10. Statistical analysis of estimated blood loss vs. change in hemoglobin yielded a correlation coefficient of 0.189 and a p value of 0.008. See Table 2 for the other correlation coefficients and p values of EBL vs. change in hematocrit, surgical time, and intravenous fluids along with change in hemoglobin vs. surgical time, intravenous fluids and change in hematocrit.
RESULTS

Review
We used multiple linear regression to obtain a model to predict change in hemoglobin based on EBL and the intravenous fluids received. The model is as follows: predicted change in hemoglobin = 1.001 x estimated blood loss (in liters) + 0.441 x IV fluids received (in liters) + 2.334. The limitations of our study include the fact that only patients undergoing orthopedic procedures were included in the study. In addition, the scope of the study was limited to data recorded by only six to eight surgeons. Similar studies in the future would benefit from expanding the scope to include non-orthopedic surgeries, and include a greater population of surgeons estimating blood loss.
The formula can predict the change in hemoglobin in non-transfused orthopedic patients. Non-orthopedic patients or those patients who have received a blood transfusion were not included in the study and therefore cannot be accurately assessed using the equation. Indeed, this is one of the limitations of not only the formula, but also the study due to the high prevalence of blood transfusion (46%-84%) (3, (17) (18) (19) , even when EBL is minimal. Accurately predicting the postoperative hemoglobin may prevent many unnecessary blood transfusions and all the complications that lie therein.
Clinically estimated blood loss appears to be an accurate predictor of postoperative hemoglobin and, when interpreted correctly, may prevent unnecessary blood transfusions and give treating physicians a clear idea of the extent of perioperative hemorrhage.
There is clearly a need for more information regarding transfusion requirements concerning surgical patients. We hope that our results (with the novel formula) will contribute to the fund of knowledge concerning the management of hemostasis in the perioperative phase.
